- Home
- LI vs NBIX Comparison
LI vs NBIX Comparison
Compare LI & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | NBIX |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5B | 15.2B |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | LI | NBIX |
|---|---|---|
| Price | $16.37 | $135.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 21 |
| Target Price | $21.04 | ★ $177.14 |
| AVG Volume (30 Days) | ★ 4.1M | 1.1M |
| Earning Date | 11-26-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.44 |
| EPS | 0.62 | ★ 4.19 |
| Revenue | ★ $17,952,966,790.00 | $2,682,700,000.00 |
| Revenue This Year | N/A | $23.68 |
| Revenue Next Year | $26.33 | $18.47 |
| P/E Ratio | ★ $27.08 | $32.34 |
| Revenue Growth | N/A | ★ 19.61 |
| 52 Week Low | $16.11 | $84.23 |
| 52 Week High | $33.12 | $160.18 |
Technical Indicators
Market Signals| Indicator | LI | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 35.89 | 35.90 |
| Support Level | $16.82 | $134.20 |
| Resistance Level | $17.74 | $142.16 |
| Average True Range (ATR) | 0.43 | 3.06 |
| MACD | 0.07 | -1.08 |
| Stochastic Oscillator | 6.69 | 9.70 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.